It would be interesting, though, to assess the loss of AMPKα2 in other mouse models of medulloblastoma with lower incidence/longer latency [47,48], in order to investigate which of AMPKα2’s roles, tumor-suppressive or pro-tumorigenic, prevails in these contexts. This evidence concerns the gene PRKAA2 and medulloblastoma.